Characterization of a novel microRNA involved in myelination: a new potential pathogenetic mechanism in multiple sclerosis

Project

Contributors (2)

LECCA DAVIDE Scientific Manager

MARANGON DAVIDE Participant

Departments involved

Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti Principale

Type

CAR_RIC - Bandi Fondazione Cariplo

Funder

FONDAZIONE CARIPLO

External Organization Funding Organization

Date/time interval

July 1, 2015 - October 31, 2017

Project duration

28 months

Concepts (6)

ATECO

72.11.00 - Ricerca e sviluppo sperimentale nel campo delle biotecnologie

ERC field

LS3_5 - Cell differentiation, physiology and dynamics - (2013)

LS5_11 - Neurological disorders (e.g. Alzheimer’s disease, Huntington’s disease, Parkinson’s disease) - (2013)

LS5_2 - Molecular and cellular neuroscience - (2013)

LS5_6 - Developmental neurobiology - (2013)

LS7_3 - Pharmacology, pharmacogenomics, drug discovery and design, drug therapy - (2013)

Outputs (2)

Mir-125a-3p negatively regulates oligodendrocyte precursor cells maturation and is altered in human multiple sclerosis

GLIA
WILEY

2017

Abstract

Partially Open Access

In vivo silencing of miR-125a-3p promotes myelin repair in models of white matter demyelination

GLIA
WILEY BLACKWELL SCIENCE

2020

Academic Article

Partially Open Access

Altmetric is disabled. Enable it on "Use of Cookies"